New research published in the journal PLOS ONE calls into question the safety and effectiveness of a popular class of pharmaceutical drugs used to treat gastroesophageal reflux disease, or GERD, as well as its less extreme companion acid reflux. Researchers found that proton-pump inhibitors, or PPIs, which millions of Americans rely on to treat heartburn symptoms, also … Continue reading Proton-pump inhibitor drugs for heartburn linked to heart attacks
